Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
FAO/WHO (Food and Agriculture Organization/World Health Organization). Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Cordoba, Argentina, 2001.
ESPGHAN Committee on Nutrition Medical Position Paper Probiotic Bacteria in Dietetic Products for Infants: a commentary by the ESPGHAN Committee on nutrition. J Paediatr Gastroenterol Nutr, 2004;38:365–374.
Menard S, Candalh C, Bambou JC, et al. Lactic acid bacteria secrete metabolites retaining anti-inflammatory proprieties after intestinal transport. Gut, 2004;53:821–828.
Kalliomaki A, Isolauri E, Probiotics and down-regulation of the allergic response. Immunol Allergy Clin N Am, 2004;24:739–752.
Thoreux K, Senegas-Balas F, Bernard-Perrone F, Giannarelli S, Denariaz G, Bouley C, Balas D. Modulation of proliferation, second messenger levels, and morphotype expression of the rat intestinal epithelial cell line IEC-6 by fermented milk. J Dairy Sci, 1996;79(1):33–43.
Aattour N, Bouras M, Tome D, et al. Oral ingestion of lactic-acid bacteria by rats increases lymphocyte proliferation and interferon-gamma production. Br J Nutr, 2002;87:367–373.
Kaila M, Isolauri E, Soppi E, et-al.. Enhancement of the circulating antibody secreting cell response in human diarrhoea by a human Lactobacillus strain. Pediatr Res, 1992;32:141–144.
Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, inter-leukin-6 and interleukin-10 is induced by lactic acid bacteria. Infect Immun, 1996;64: 5403–5405.
Guandalini S. Acute diarrhea. In: Walzer WA, Durie PR, Hamilton JR, Walker-Smith JA, Watkins JB, Ed., Pediatric gastrointestinal disease-pathophysiology, diagnosis, management, 3rd ed. Ontario, BC Decker, 2000:28–38.
Guarino A, Albano F, Guandalini S, for the ESPGHAN Working group on Acute Diarrhoea. Oral rehy-dration solution: toward a real solution. J Paediatr Gastroenterol Nutr, 2001;33:S2–12.
Isolauri E, Juntunen M, Rautanen T, et-al.. A human Lactobacillus strain (Lactobacillus casei strain GG) promotes recovery from acute diarrhoea in children. Pediatrics, 1991;88:90–97.
Majamaa H, Isolauri E, Saxelin M and Vesikari T. Lactic acid bacteria in the treatment of acute Rotavirus Gastroenteritis. J Paediatr Gastroenterol Nutr, 1995;20:333–338.
Shornikova AV, Isolauri E, Burkanova L, Lukovnikova S, Vesikari T. A trial in the Karelian Republic of oral rehydration and Lactobacillus GG for treatment of acute diarrhoea. Acta Paediatr 1997;86(5):460–465.
Guandalini S, Pensabene L, Zikri M, et-al.. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhoea: a multicenter European trial. J Paediatr Gastroenterol Nutr 2000;30:54–60.
Szymanski H, Pejcz J, Jawien M, Chmielarczyks A, Strus M, Heczko. Treatment of acute infectious diarrhoea in infants and children with a mixture of three Lactobacillus rhamnosus strains – a randomized, double blind, placebo controlled trial. Aliment Pharmacol Ther, 2006;23:247–253.
Pedone CA, Bernabeu AO, Postaire, et-al.. The effect of supplementation with milk fermented by Lactobacillus casei (strain DN114 001) on acute diarrhoea in children attending day care centres. Int J Clin Practice, 1999;53:179–184.
Pedone CA, Arnaud CC, Postaire ER, et-al.. Multicenter study of the effects of milk fermented by Lactobacillis casei on the incidence of diarrhoea. Int J Clin Practice, 2000;54:567–571.
Rosenfeldt V, Michaelsen K, Jakobsen M, et-al.. Effect of probiotic Lactobacillus strains in young children hospitalized with acute diarrhoea. Pediatr Infect Dis J, 2002;21:411–416.
Rosenfeldt V, Michaelsen K, Jakobsen M, et-al.. Effect of probiotic Lactobacillus strains on acute diarrhoea in a cohort of non-hospitalized children attending day-care centers. Pediatr Infect Dis J 2002;21:417–419.
Weizman Z, Ghaleb A, Alsheikh A. Effect of probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics, 2005;115:5–9.
Costa-Ribeiro H, Ribeiro T, Mattos A, et-al. Limitation of probiotic therapy in acute, severe dehydrating diarrhoea. J Paediatr Gastroenterol Nutr, 2003;36:112–115.
Salazar-Lindo E, Langschwager P, Campos-Sanchez M, Chea-Woo E and Sack B Lactobacillus casei strain GG in the treatment of infants with acute watery diarrhoea: a randomized, double blind, placebo controlled clinical trial. BMC Paediatr, 2004;4:18.
Sarker S, Sultana S, Fuchs G, et-al. Lactobacillus paracasei strain ST11 has no effect on Rotavirus but ameliorate the outcome of nonrotavirus diarrhoea in children from Bangladesh. Pediatrics 2005;116:e221–228.
Kugurol Z, Koturoglu G. Effects of Saccharomyces boulardii in children with acute diarrhoea. Acta Paediatr, 2005;94:44–47.
Villarruel G, Martinez Rubio D, Lopez F, Cintioni J, Gurevech R, Romero G Saccharomyces boulardii in acute childhood diarrhoea: a randomized, placebo-controlled study. Acta Paediatr 2007;96:538–541.
Billoo AG, Memon MA, Khaskheli SA, et-al.. Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea. World J Gastroenterol, 2006;28:4557–4560.
Thibault H, Aubert-Jacquin C and Goulet O. Effect of long-term consumption of a fermented infant formula (with Bifidobacterium breve c50 and Streptococus thermophilus 065) on acute diarrhoea in healthy infants. J Paediatr Gastroenterol Nutr, 2004;39:147–152.
Szajewska H, Mrukowicz J. Probiotics in the treatment and prevention of acute infectious diarrhoea in infants and children: a systematic review of published randomized, double blind, placebo-controlled trials. J Paediatr Gastroenterol Nutr, 2001;33:S17–S25.
Huang J, Bousvaros A, Lee J, Diaz A, Davidson E. Efficacy of probiotic use in acute diarrhoea in children a meta-analysis. Dig Dis Sci, 2002;47:2625–2634.
Van Niel C, Feudtner C, Garrison M, Christakis D. Lactobacillus therapy for acute infectious diarrhoea in children: a meta-analysis. Pediatrics, 2002;109:678–684.
D'Souza AL, Rajkumar C, Cooke J, et-al.. Probiotics in prevention of antibiotic associated diarrhea: meta-analysis. BMJ, 2002;324:1–6.
Vanderhoof J, Whitney D, Antonson D, et-al.. Lactobacillus GG in the prevention of antibiotic associated diarrhea in children. J Paediatr, 1999;135(5):564–535.
Correa N, Filho LP, Penna F, Lima F, and Vicoli J. A randomized formula controlled trial of Bifidobacterium lactis and Streptococcus thermophilus for prevention of antibiotic associated diarrhea in infants. J Clin Gastroenterol, 2005;39(5):385–389.
Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J Pediatr, 2001;138(3):361–365.
Mastretta E, Longo P, Laccisaglia A, et-al.. Effect of Lactobacillus GG and breast feeding in the prevention of rotavirus nosocomial infection. J Paediatr Gastroenterol Nutr, 2002;35:527–531.
Saavedra J, Bauman N, Oung I, Perman J, Yolken R. Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding rotavirus. Lancet, 1994;344:1046–1049.
Lucassen PL, Assendelft WJ, van Eijk JT, et-al. Systematic review of the occurrence of infantile colic in the community. Arch. Dis Child, 2001;84:398–403.
Rinne M, Kalliomaki M, Salminem S, Isolauri E. Probiotic intervention in the first months of life: short-term effects on gastrointestinal symptoms and long-term effects on gut microbiota. J Pediatr Gastroenterol Nutr, 2006 Aug;43(2):200–205.
Savino F, Pelle E, Palumeri E, Oggero R, Miniero R. Lactobacillus reuteri (American type culture collection strain 55730) versus simethicone in the treatment of infantile colic: a prospective randomized study. Pediatrics, 2007;119:e124–130.
Bjorksten B, Sepp A, Julge K, et-al.. Allergy development and the microflora during the first Year of life. J Allergy Clin Immunol, 2001;108:516–520.
Saavedra J, Abi-Hanna A, Moore N, Yolken R. Long term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr, 2004;79:261–267.
Hattaka K, Savilhati E, Ponka A, et-al.. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ, 2001 June 2;322(7298):1327.
Bjorksten B, Naaber P, Sepp E, et-al.. The intestinal microflora in allergic Estonian and Swedish 2-Years old children. Clin Exp Allergy, 1999;29:342–346.
Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol, 1997;99(2):179–185.
Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminem S. Probiotics in the management of atopic eczema. Clin Exp Allergy, 2000;30:1604–1610.
Rosenfeldt V, Benfeldt E, Dam Nielsen S, et-al.. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol, 2003;111:389–395.
Sistek D, Kelly R, Wickens K, Stanley T, Fitzharris P, and Crane J. Is the effect of probiotics on atopic dermatitis confined to food sensitized children. Clin Exp Allergy, 2006;36:629–633.
Viljanen M, Savilahti E, Haahtela, et-al. Probiotics in the treatment of atopic eczema/dermatitis syndrome in infants: a double-blind placebo-controlled trial. Allergy, 2005;60:494–500.
Weston S, Halbert A, Richmond P, Prescott L. Effects of probiotics on atopic dermatitis: a randomised controlled trial. Arch Dis Child, 2005;90:892–897.
Kirjavainen P, Salminem S, and Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Paediatr Gastroenterol Nutr, 2003;36:223–227.
Kalliomaki M, Salminem S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 2001;357:1076–1079.
Kalliomaki M, Salminem S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4 Year follow-up of a randomised controlled trial. Lancet, 2003;361:1869–1871.
Kalliomaki M, Salminem S, Poussa T, Isolauri E. Probiotics during the first 7 Years of life: a cumulative risk reduction of eczema in a randomised, placebo controlled trial. J Allergy Clin Immunol 2007;119(4):1019–1021.
Abrahamsson T, Jakobsson T, Bottcher M, et-al.. Probiotics in prevention of IgE-associated eczema: a double blind randomized placebo controlled trial. J Allergy Clin Immunol, 2007;119(5):1174–1180.
Brouwer M, Wolt-Plompen A, Dubois A, et-al.. No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial. Clin Exp Allergy, 2006;36:899–906
Taylor A, Dunstan J, Prescott S. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increase the risk of allergen sensitization in high-risk children: a randomized controlled trial. J Allergy Clin Immunol, 2007;119(1):184–191.
Saavedra J, Abi-Hanna A, Moore N, Yolken R. Long term consumption of infant formulas containing live probiotic bacteria: tolerance and safety. Am J Clin Nutr, 2004;79:261–267.
Boyle R, Robins-Browne R, and Tang M. Probiotic use in clinical practise: what are the risks? Am J Clin Nutr, 2006;83:1256–1264.
Kunz AN, Noel JM, Fairchok MP. Two cases of Lactobacillus bacteraemia during probiotic treatment of short gut syndrome. J Pediatr Gastroenterol Nutr, 2004;38:457–458.
Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics, 2005;115(1):178–181.
Donohue D, Salminem S, Martial P. Safety of probiotic bacteria. In: Salminen S, von Wright A, Ed., Lactic acid bacteria. Marcel Dekker, New York, 1998:369–384.
Marteau P, Gerhardt MF, Myara A, et-al. Bifidobacteria and Lactobacilii ingested in fermented dairy products can metabolized bile salts in the human small intestine. Microbiol Ecol Health Dis. 8;151–157.
Ruseler V, Lieshout LM, Gosselink MJ, Inability of Lactobacillus casei strain GG, L. acidophilus and Bifidobacterium bifidum to degrade intestinal mucus glycoproteins: clearing the way for mucosa-protective therapy. Scand J Gastroenterol, 1995;30:675–680.
Olukoya DK, Ebigwei SI, Adebawo OO, Osiyemi FO. Plasmid profile and antibiotic susceptibility patterns of Lactobacillus isolated from fermented food in Nigeria. Food Microbiol, 1993;10:279–285.
Tynkkynen S, Singh KV, Varmenen P, Vancomycin resistance factor of Lactobacillus rhamnosus GG in relation to enterococcal vancomycin resistance van genes. Int J Food Microbiol, 1998;41:195–204.
Salminem S, Wright A, Morelli L, et-al.. Demonstration of safety of probiotics – a review. Int J Food Microbiol, 1998;44:93–106.
Vescovo M, Morelli L, and Bottazzi V. Drug resistance Plasmids in Lactobacillus acidophilus and Lactobacillus reuteri. Appl Envir Microbiol, 1982;43(1):50–56.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science + Business Media, LLC
About this chapter
Cite this chapter
Agostoni, C., Salvini, F. (2009). Probiotics in Infant Dietetics. In: Michail, S., Sherman, P.M. (eds) Probiotics in Pediatric Medicine. Nutrition and Health Series. Humana Press. https://doi.org/10.1007/978-1-60327-289-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-60327-289-6_8
Publisher Name: Humana Press
Print ISBN: 978-1-60327-288-9
Online ISBN: 978-1-60327-289-6
eBook Packages: MedicineMedicine (R0)